Search results for "Highlights"
Drug-eluting stents may not confer advantage in diabetic patients
An editorial noted that drug-eluting stents may work for noncomplex lesions in patients with diabetes, but complex disease states incurred high rates of myocardial infarction and revascularization.
https://diabetes.acponline.org/archives/2019/01/11/3.htm
11 Jan 2019
Consensus report updates evidence on managing hyperglycemia in patients with type 2 diabetes
The American Diabetes Association and the European Association for the Study of Diabetes updated their 2018 recommendations based on trials published in 2019.
https://diabetes.acponline.org/archives/2020/01/10/1.htm
10 Jan 2020
Cardiovascular event rates similar among newer second-line medications for type 2 diabetes
The comparison of dipeptidyl peptidase-4 inhibitors with other drug classes did find higher rates of major adverse cardiovascular events with basal insulin, sulfonylureas, and meglitinides than with the newer drugs.
https://diabetes.acponline.org/archives/2019/01/11/2.htm
11 Jan 2019
SGLT2 inhibitors associated with increased risk of amputations, diabetic ketoacidosis
Sodium-glucose cotransporter 2 (SGLT2) inhibitors and glucagon-like peptide-1 receptor agonists had similar rates of other adverse events, including bone fracture, acute kidney injury, serious urinary tract infection, venous thromboembolism, and acute pancreatitis.
https://diabetes.acponline.org/archives/2018/12/14/3.htm
14 Dec 2018
New equation with five variables helps predict hip fracture risk in type 2 diabetes
Age, sex, body mass index, peripheral sensory neuropathy, and estimated glomerular filtration rate were the included variables.
https://diabetes.acponline.org/archives/2018/12/14/2.htm
14 Dec 2018
No link between vitamin D, omega-3 fatty acid supplements and improved kidney function
An ancillary analysis of the Vitamin D and Omega-3 Trial (VITAL) included 1,312 adult patients with type 2 diabetes who agreed to additional testing of kidney function and urinary albumin excretion at baseline and two and five years after randomization.
https://diabetes.acponline.org/archives/2019/12/13/1.htm
13 Dec 2019
Mortality benefit of tighter glycemic control may vary by diabetes duration, study finds
Mortality risk increased with worse glycemic control among patients who had had diabetes for less than five years, while a mean HbA1c level between 6.5% to 7.9% was associated with the lowest mortality risk in those who had had the disease longer.
https://diabetes.acponline.org/archives/2019/11/08/1.htm
8 Nov 2019
Incretin-based drugs not associated with any increase in risk for pancreatic diseases
The findings may reassure prescribers of dipeptidyl peptidase-4 inhibitors that the drug class does not significantly increase the risk of adverse pancreatic outcomes compared with other second-line therapies, study authors said.
https://diabetes.acponline.org/archives/2018/11/09/3.htm
9 Nov 2018
Spotlight on depression in diabetes
Recent studies analyzed depression in diabetes, including associated causes of death, the potential benefits of peer support and a plant-based diet, and strategies for screening and treatment.
https://diabetes.acponline.org/archives/2018/11/09/5.htm
9 Nov 2018
Metformin associated with fewer cardiovascular events than sulfonylureas after decline in kidney function
The findings from this retrospective study further support metformin as the first-line treatment to which other diabetes medications are added, even in patients who are in the early stages of chronic kidney disease, an editorial noted.
https://diabetes.acponline.org/archives/2019/10/11/1.htm
11 Oct 2019